*Some Market data delayed by 15 mins.

Insulet Corporation

Symbol: PODD (NASDAQ)
305.81 ▼ (-0.95%) -2.925

Company Description:
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Key Stats
  • Today's Open: $308.75
  • Today's High: $319.755
  • Today's Low: $290.01
  • Today's Volume: 1.14M
  • Yesterday Close: $308.73
  • Yesterday High: $311.41
  • Yesterday Low: $304.64
  • Yesterday Volume: 985.77K
  • Last Min Volume: 2
  • Last Min High: $305.805
  • Last Min Low: $305.805
  • Last Min VWAP: $305.805
Company Profile
  • Name: Insulet Corporation
  • Website: https://www.insulet.com
  • Listed Date: 2007-05-15
  • Location: ACTON, MA
  • Market Status: Active
  • CIK Number: 0001145197
  • SIC Code: 3841
  • SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Market Cap: $21.73B
  • Round Lot: 100
  • Outstanding Shares: 70.39M
  • Asset Type: CS
RECENT FILINGS FOR PODD
Filing Date Filing Type Format
2025-09-16 144 View
2025-09-16 8-K View
2025-09-09 4 View
2025-09-09 4 View
2025-09-08 144 View
2025-09-08 144 View
2025-08-22 4 View
2025-08-21 4 View
2025-08-21 144 View
2025-08-13 SCHEDULE 13G/A View
2025-08-08 4 View
2025-08-07 10-Q View
2025-08-07 144 View
2025-08-07 8-K View
2025-08-05 4 View
2025-07-29 3 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-13 144 View
2025-06-13 144 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.